Aditya Bardia

Also affiliated with UCLA Health, Amyotrophic Lateral Sclerosis Therapy Development Institute, Massachusetts General Hospital, USC Norris Comprehensive Cancer Center, Comprehensive Blood & Cancer Center, Center for Cancer Research

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile

1.0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Circulating tumour DNA characterisation of invasive lobular carcinoma in patients with metastatic breast cancer

EBioMedicine(2022)10.1016/j.ebiom.2022.104316

Top 20%

1.0DataRank

Top 20%17 citations

Lorenzo Gerratana, Katherine Clifton, Arielle J. Medford, Marko Velimirovic, Whitney L. Hensing +17 more

Papers

Driven by 28 papers — median percentile 80. Top paper: “Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study”.

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

The Lancet(2020)10.1016/s0140-6736(20)31187-9

N/A

11.9DataRank · unranked

1804 citations

Toni K. Choueiri, Dimpy P. Shah, Yu Shyr, Samuel M. Rubinstein, Donna R. Rivera +95 more

Sacituzumab govitecan in previously treated hormone receptor-positive/HER2-negative metastatic breast cancer: final results from a phase I/II, single-arm, basket trial

Annals of Oncology(2020)10.1016/j.annonc.2020.09.004

N/A

5.0DataRank · unranked

145 citations

Jennifer R. Diamond, Linda T. Vahdat, Sara M. Tolaney, Dejan Juric, Joyce O’Shaughnessy +11 more

Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study

Journal of Clinical Oncology(2021)10.1200/jco.21.01891

N/A

3.8DataRank · unranked

94 citations

Claire A. Pernat, Alexander Gavralidis, Kerri St. Denis, Evan C. Lam, Laura M. Spring +41 more

AMEERA-1 phase 1/2 study of amcenestrant, SAR439859, in postmenopausal women with ER-positive/HER2-negative advanced breast cancer

Nature Communications(2022)10.1038/s41467-022-31668-8

N/A

2.0DataRank · unranked

54 citations

Sarat Chandarlapaty, Hannah M. Linden, Gary A. Ulaner, Alice Gosselin, Sylvaine Cartot‐Cotton +12 more

Circulating tumour DNA characterisation of invasive lobular carcinoma in patients with metastatic breast cancer

EBioMedicine(2022)10.1016/j.ebiom.2022.104316

Top 20%

1.0DataRank

Top 20%17 citations

Lorenzo Gerratana, Katherine Clifton, Arielle J. Medford, Marko Velimirovic, Whitney L. Hensing +17 more

Intercellular nanotubes mediate mitochondrial trafficking between cancer and immune cells

Nature Nanotechnology(2021)10.1038/s41565-021-01000-4

N/A

0.902DataRank · unranked

408 citations

Chinmayee Dash, Ruparoshni Jayabalan, Sachin Khiste, Arpita Kulkarni, Kiran Kurmi +6 more

Deregulation of ribosomal protein expression and translation promotes breast cancer metastasis

Science(2020)10.1126/science.aay0939

N/A

0.891DataRank · unranked

379 citations

Sooncheol Lee, Ben S. Wittner, Kira Niederhoffer, Benjamin Nicholson, Aditya Bardia +20 more

Implementation and Clinical Adoption of Precision Oncology Workflows Across a Healthcare Network

The Oncologist(2022)10.1093/oncolo/oyac134

N/A

0.867DataRank · unranked

22 citations

Rebecca S. Heist, Adam Z. Bard, Annacarolina F L da Silva, Ibiayi Dagogo‐Jack, Valentina Nardi +45 more

Parallel Genomic Alterations of Antigen and Payload Targets Mediate Polyclonal Acquired Clinical Resistance to Sacituzumab Govitecan in Triple-Negative Breast Cancer

Cancer Discovery(2021)10.1158/2159-8290.cd-21-0702

N/A

0.818DataRank · unranked

233 citations

Sheng Sun, Ignaty Leshchiner, Nayana Thimmiah, Elizabeth E. Martin, Daniel E. McLoughlin +17 more

Phase Ia/b Study of Giredestrant ± Palbociclib and ± Luteinizing Hormone-Releasing Hormone Agonists in Estrogen Receptor–Positive, HER2-Negative, Locally Advanced/Metastatic Breast Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1796

N/A

0.680DataRank · unranked

24 citations

Meritxell Bellet, Nicholas C. Turner, Sherene Loi, Aditya Bardia, Valentina Boni +17 more

Sequential use of antibody-drug conjugate after antibody-drug conjugate for patients with metastatic breast cancer: ADC after ADC (A3) study.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.1022

N/A

0.604DataRank · unranked

55 citations

Laura M. Spring, Geoffrey Fell, Phoebe Ryan, Neelima Vidula, Arielle J. Medford +8 more

TOP1 Mutations and Cross-Resistance to Antibody–Drug Conjugates in Patients with Metastatic Breast Cancer

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-2771

N/A

0.574DataRank · unranked

45 citations

Bogang Wu, Haley Barnes, Arielle J. Medford, Bryanna L. Norden, Annika Putur +16 more

A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance

Cancer Cell(2020)10.1016/j.ccell.2020.10.022

N/A

0.529DataRank · unranked

33 citations

David M. Aboulafia, Melissa Accordino, Jared D. Acoba, Manmeet S. Ahluwalia, Syed A. Ahmad +95 more

Identification of Somatically Acquired BRCA1/2 Mutations by cfDNA Analysis in Patients with Metastatic Breast Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-0638

N/A

0.483DataRank · unranked

24 citations

Taronish D. Dubash, Michael S. Lawrence, Antoine Simoneau, Andrzej Niemierko, Erica Blouch +24 more

Randomized Phase III Study of Amcenestrant Plus Palbociclib Versus Letrozole Plus Palbociclib in Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Primary Results From AMEERA-5

Journal of Clinical Oncology(2024)10.1200/jco.23.02036

N/A

0.434DataRank · unranked

17 citations

Sara A. Hurvitz, Joyce O'Shaughnessy, Suzette Delaloge, Hiroji Iwata, Hope S. Rugo +11 more

A Gene Panel Associated With Abemaciclib Utility in ESR1-Mutated Breast Cancer After Prior Cyclin-Dependent Kinase 4/6-Inhibitor Progression

JCO Precision Oncology(2023)10.1200/po.22.00532

N/A

0.425DataRank · unranked

16 citations

Taronish D. Dubash, Gabriela N. Johnson, Andrzej Niemierko, Veronica Mariotti, Leslie S.L. Kim +27 more

A bedside-to-bench translational analysis of NF1 alterations and CDK4/6 inhibitor resistance in hormone receptor-positive metastatic breast cancer

EBioMedicine(2025)10.1016/j.ebiom.2025.105828

N/A

0.404DataRank · unranked

7 citations

Rosario Chica-Parrado, Caroline Weipert, Todd C. Knepper, Emily Podany, Fabiana Napolitano +21 more

Interplay between ESR1/PIK3CA codon variants, oncogenic pathway alterations and clinical phenotype in patients with metastatic breast cancer (MBC): comprehensive circulating tumor DNA (ctDNA) analysis

Breast Cancer Research(2023)10.1186/s13058-023-01718-0

N/A

0.396DataRank · unranked

13 citations

Andrew A. Davis, Marko Velimirovic, Katherine Clifton, Whitney L. Hensing, Ami N. Shah +13 more

A TROP2/Claudin Program Mediates Immune Exclusion to Impede Checkpoint Blockade in Breast Cancer

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.12.02.626446

N/A

0.269DataRank · unranked

5 citations

Win Thant, Elena Bitman, Ting Liu, Jie Liu, Eleftherios I. Paschalis +17 more

Reconstructing tumor trajectories during therapy through integration of multiple measurement modalities

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.01.14.426737

N/A

0.165DataRank · unranked

2 citations

Jinfeng Chen, Onalisa Winblad, Anne O’Dea, Priyanka Sharma, Meghna S. Trivedi +13 more

CDKN1B (p27/kip1) enhances drug-tolerant persister CTCs by restricting polyploidy following mitotic inhibitors

Proceedings of the National Academy of Sciences(2025)10.1073/pnas.2507203122

N/A

0.165DataRank · unranked

2 citations

Taronish D. Dubash, Annamária Szabolcs, Ben S. Wittner, Johannes Kreuzer, Robert Morris +15 more

Mechanisms of Resistance to Antibody–Drug Conjugates

Cancers(2023)10.3390/cancers15041278

N/A

0DataRank · unranked

140 citations

Bogang Wu, Laura M. Spring, Leif W. Ellisen, Aditya Bardia, Rachel O. Abelman

Data from Phase Ia/b Study of Giredestrant ± Palbociclib and ± Luteinizing Hormone-Releasing Hormone Agonists in Estrogen Receptor–Positive, HER2-Negative, Locally Advanced/Metastatic Breast Cancer

(2024)10.1158/1078-0432.c.7077719

N/A

0DataRank · unranked

0 citations

Meritxell Bellet, Nicholas C. Turner, Sherene Loi, Aditya Bardia, Valentina Boni +17 more

Data from Phase Ia/b Study of Giredestrant ± Palbociclib and ± Luteinizing Hormone-Releasing Hormone Agonists in Estrogen Receptor–Positive, HER2-Negative, Locally Advanced/Metastatic Breast Cancer

(2024)10.1158/1078-0432.c.7077719.v1

N/A

0DataRank · unranked

0 citations

Meritxell Bellet, Nicholas C. Turner, Sherene Loi, Aditya Bardia, Valentina Boni +17 more

Convergent evolution of resistance pathways during early stage breast cancer treatment with combination cell cycle (CDK) and endocrine inhibitors

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.01.19.427299

N/A

0DataRank · unranked

0 citations

Jinfeng Chen, Patrick A. Cosgrove, Anne O’Dea, Priyanka Sharma, X. Cynthia +13 more

Modeling the novel SERD elacestrant in cultured fulvestrant-refractory HR-positive breast circulating tumor cells

Breast Cancer Research and Treatment(2023)10.1007/s10549-023-06998-w

N/A

0DataRank · unranked

6 citations

Aditya Bardia, Brian Chirn, Brittany A. Reeves, Joseph A. LiCausi, Risa Burr +18 more

Allosteric PI3Kα Inhibition Overcomes On-target Resistance to Orthosteric Inhibitors Mediated by Secondary PIK3CA Mutations

Cancer Discovery(2023)10.1158/2159-8290.cd-23-0704

N/A

0DataRank · unranked

61 citations

Ferran Fece de la Cruz, Elizabeth E. Martin, Bryanna L. Norden, Nicholas Chevalier, Allison M. Kehlmann +26 more

Association of pretreatment chest CT abnormalities with trastuzumab deruxtecan–associated pneumonitis.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.1106

N/A

0DataRank · unranked

0 citations

Zachary Hartley-Blossom, Geoffrey Fell, Phoebe Ryan, Erika Nakajima, Beverly Moy +5 more

Aditya Bardia

Indexed papers

Top data-sharing exemplar

Papers